EUVIMEDEUVIMED entdecken
Open Access

Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia

Caroline R M Wiggers iD, Burak Yüzügüldü iD, Nathanial G Tadros iD, Tayla B Heavican-Foral iD, Eugene Y Cho iD, Zachary C Eisenbies, Merve Ozdemir iD, Steffen B Kulp iD, Yun-Cheol Chae, Alejandro Gutierrez iD, Jens G Lohr iD, Birgit Knoechel iD

Science Advances · 2025

DOI: 10.1126/sciadv.ads8351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Caroline R M Wiggers und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Galectins, Interferon Regulatory Factor-1, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Galectin-9 is overexpressed in a variety of cancers and associated with worse clinical outcome in some cancers. However, the regulators driving Galectin-9 expression are unknown. Here, we defined the transcriptional regulators and epigenetic circuitry of Galectin-9 in pediatric T cell acute lymphoblastic leukemia (T-ALL), as an example of a disease with strong Galectin-9 expression, in which higher expression was associated with lower overall survival. By performing a genome-wide CRISPR screen, we identified the transcription factors IRF1 and TFAP4 as key regulators for Galectin-9 expression by binding its regulatory elements. Whereas IRF1 was observed exclusively on the promoter, TFAP4 binding was detected at an enhancer solely in T-ALL cells associated with higher Galectin-9 levels. Together, our results show that IRF1 is responsible and indispensable for Galectin-9 expression and TFAP4 further fine-tunes its expression. Our approach, a flow-based genome-wide CRISPR screen complemented by transcription factor binding and enhancer mapping, creates innovative opportunities for understanding and manipulating epigenetic transcriptional regulation in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor T-Cell Lymphoblastic Leukemia-LymphomaGalectinsInterferon Regulatory Factor-1Transcription FactorsGene Expression Regulation, LeukemicCRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsHumansPromoter Regions, GeneticCell Line, TumorGene Expression Regulation, NeoplasticEnhancer Elements, GeneticProtein BindingEpigenesis, Genetic

Substanzen

LGALS9 protein, humanGalectinsInterferon Regulatory Factor-1Transcription FactorsIRF1 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

ORCID-Profile: Caroline R M Wiggers, Burak Yüzügüldü, Nathanial G Tadros, Tayla B Heavican-Foral, Eugene Y Cho, Merve Ozdemir, Steffen B Kulp, Alejandro Gutierrez, Jens G Lohr, Birgit Knoechel

Förderung

  • NCI NIH HHS

Zitieren

APA

Wiggers, C. R. M., Yüzügüldü, B., Tadros, N. G., Heavican-Foral, T. B., Cho, E. Y., Eisenbies, Z. C., Ozdemir, M., Kulp, S. B., Chae, Y. C., Gutierrez, A., Lohr, J. G., & Knoechel, B. (2025). Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia. Science Advances. https://doi.org/10.1126/sciadv.ads8351

Vancouver

Wiggers CRM, Yüzügüldü B, Tadros NG, Heavican-Foral TB, Cho EY, Eisenbies ZC, et al. Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia. Science Advances. 2025. doi:10.1126/sciadv.ads8351

BibTeX
@article{Wiggers2025,
  author = {Wiggers, Caroline R M and Yüzügüldü, Burak and Tadros, Nathanial G and Heavican-Foral, Tayla B and Cho, Eugene Y and Eisenbies, Zachary C and Ozdemir, Merve and Kulp, Steffen B and Chae, Yun-Cheol and Gutierrez, Alejandro and Lohr, Jens G and Knoechel, Birgit},
  title = {Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.ads8351}
}
Kostenlos starten →